Magle Chemoswed Holding AB (publ) Magle Chemoswed Holding AB (publ)

Magle Chemoswed Holding AB (publ)

MAGLE

Rank in Stocks #33363
Magle Chemoswed Holding AB (publ), based in Malmö, Sweden, specializes in the... Magle Chemoswed Holding AB (publ), based in Malmö, Sweden, specializes in the research, development, and manufacturing of products within the pharmaceutical chemistry and technology sectors. The company's core activities include the process development and production of Active Pharmaceutical Ingredients (APIs), as well as the innovation and manufacturing of advanced wound care and diagnostic products, primarily leveraging its proprietary degradable starch microsphere technology. Its API portfolio features Warfarin sodium, used as an anticoagulant; Melperone hydrochloride, an antipsychotic agent; Isradipine, a calcium channel blocker for hypertension; Amantadine sulfate, for central nervous system disorders; and Benserazide hydrochloride, utilized with L-Dopa in Parkinson's disease treatment. Furthermore, Magle Chemoswed offers a range of medical devices for advanced wound care, surgical diagnostics, and drug delivery. These include EmboCept S, a microsphere-based device for vascular occlusion in liver and lung tumors; SmartGel, an innovative non-allergenic hydrogel derived from their microsphere platform; SmartPAN, a diagnostic tool for detecting pancreatic fluid leakage during surgical procedures; and EmboCept M, designed for managing benign prostatic hyperplasia. The company provides contract services to the pharmaceutical and medical device industries. Founded in 1944, Magle Chemoswed Holding AB (publ) operates as a subsidiary of Magle AB.
Share Price
$0.02547704
Last synced: 2026-11-12
Market Cap
$526.08K
Change (1 day)
-1.00%
Change (1 year)
-98.68%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade Magle Chemoswed Holding AB (publ) (MAGLE)

Category

Healthcare
EPS for Magle Chemoswed Holding AB (publ) (MAGLE)
EPS as of June 2026 TTM: $-0.82
According to Magle Chemoswed Holding AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.82. At the end of 2025 the company had an EPS of $-0.84, a decrease compared to its 2024 EPS of $0.08.
EPS history for Magle Chemoswed Holding AB (publ) from 2017 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.82 -2.75%
2025 $-0.84 -1,095.02%
2024 $0.08 -24.73%
2023 $0.11 37.42%
2022 $0.08 71.58%
2021 $0.05 63.79%
2020 $0.03 267.09%
2019 $0.01 -122.07%
2018 $-0.04 -129.56%
2017 $0.12 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.66 -2,017.00%
US
$-7.07 765.47%
US
$-5.29 547.57%
AU
$12.73 -1,658.60%
BE
$21.56 -2,739.25%
NL

Questions about Magle Chemoswed Holding AB (publ)'s earnings per share (EPS)

What is Magle Chemoswed Holding AB (publ)'s earnings per share (EPS)?

Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.82, as of Jun 2026.

What was Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) in 2025?

In 2025, Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) was $-0.84, compared with $0.08 in 2024.

How has Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) was highest in 2023 ($0.11) and lowest in 2025 ($-0.84).

How does Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) compare with similar companies?

Magle Chemoswed Holding AB (publ)'s earnings per share (EPS) ($-0.82) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.